Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Data Collection × 1 year × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Pancreatic Neoplasms 2 Pancreatic Cyst 2 Neoplasm Metastasis 2 Wilms Tumor 1 Uveal Melanoma 1 Thyroid Nodule 1 Thyroid Diseases 1 Prostatic Neoplasms 1 Peutz-Jeghers Syndrome 1 Pancreatitis, Chronic 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Myasthenia Gravis 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia 1 Intestinal Neuroendocrine Tumor 1 Hyperthyroidism 1 Hip Fractures 1 Hematologic Neoplasms 1 Goiter 1 Frailty 1 Fractures, Spontaneous 1 Financial Stress 1 Endometrial Neoplasms 1 Dysplastic Nevus Syndrome 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1

Interventions

Cyclophosphamide 58 Rituximab 47 fludarabine 38 fludarabine phosphate 25 obinutuzumab 17 venetoclax 16 Lenalidomide 16 ibrutinib 15 Etoposide 14 Prednisone 13 pirtobrutinib 12 Whole-Body Irradiation 12 Mycophenolic Acid 11 Melphalan 11 Bendamustine Hydrochloride 11 Tacrolimus 10 Specimen Handling 10 Filgrastim 10 Doxorubicin 10 Biopsy 10 Vincristine 9 Magnetic Resonance Spectroscopy 9 Granulocyte Colony-Stimulating Factor 9 pembrolizumab 8 Stem Cell Transplantation 8 Peripheral Blood Stem Cell Transplantation 8 Nivolumab 8 Gemcitabine 8 Cytarabine 8 tocilizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05583318 2025-07-23

LymphoVie 2

Centre Hospitalier Universitaire Dijon

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡